Document is current
Any future updates will be listed below
-
Authors
Fontanilles, Maxime http://orcid.org/0000-0003-4350-7349
Marguet, Florent
Beaussire, Ludivine
Magne, Nicolas
Pépin, Louis-Ferdinand
Alexandru, Cristina
Tennevet, Isabelle
Hanzen, Chantal
Langlois, Olivier
Jardin, Fabrice
Laquerrière, Annie
Sarafan-Vasseur, Nasrin
Di Fiore, Fréderic
Clatot, Florian
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02617745 at ClinicalTrials.govDocuments that mention this clinical trial
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
https://doi.org/10.1186/s40478-020-01057-7
Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.
https://doi.org/10.1200/jco.2023.41.16_suppl.2025
- License Information
-
More Information
Article History
Received: 26 August 2020
Accepted: 10 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: An informed written consent to participate to the study was obtained from all patients and the French National Committee for the Protection of Persons approved the study (RCB ID 2015-A00377-42).
: Not applicable.
: All the authors report no disclosure.
